In mice, both the hepatic over-expression of hepassocin and administration of recombinant hepassocin lead to exacerbated hepatic lipid accumulation and induction of insulin resistance in both liver and skeletal muscle tissues (46). The gene discussed is FGL1; the disease is Insulin resistance.